Amicogen, Inc. (KOSDAQ:092040)
886.00
-60.00 (-6.34%)
Nov 20, 2026, 3:30 PM KST
Amicogen Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 48,081 | 41,981 | 173,605 | 159,904 | 144,296 | 124,881 |
Revenue Growth | -45.34% | -75.82% | 8.57% | 10.82% | 15.55% | 7.79% |
Gross Profit Gross Profit Growth | 8,569 | 5,290 | 50,209 | 54,634 | 45,762 | 44,641 |
Operating Income Operating Income Growth | -12,458 | -15,375 | -9,563 | 689.42 | -4,926 | -4,627 |
Net Income Net Income Growth | -11,374 | -29,960 | -52,791 | -23,289 | -47,220 | 3,733 |
Earnings Per Share EPS Growth | -174.97 | -542.79 | -960.83 | -583.58 | -1207.54 | 96.00 |
EPS Growth | - | - | - | - | - | -88.32% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Consolidation Adjustment Consolidation Adjustment Growth | -4,418 | -3,913 | -3,432 | -15,498 | -11,645 | -8,200 |
Special Enzymes, New Bio Materials, Biopharmaceutical Material, Health and Beauty Special Enzymes, New Bio Materials, Biopharmaceutical Material, Health and Beauty Growth | 51,103 | 45,895 | 54,724 | 55,181 | 48,673 | 47,127 |
Raw Drug Substance Raw Drug Substance Growth | - | - | 122,313 | 120,222 | 107,268 | 85,930 |
Total Total Growth | 46,685 | 41,981 | 173,605 | 159,904 | 144,296 | 124,881 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 7,523 | 7,242 | 8,455 | 38,555 | 32,745 | 42,546 |
Total Debt Total Debt Growth | 55,024 | 94,149 | 119,971 | 149,595 | 144,478 | 84,722 |
Net Cash (Debt) Net Cash Growth | -47,501 | -86,907 | -111,516 | -111,040 | -111,733 | -42,176 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -730.71 | -1574.53 | -2029.67 | -2782.49 | -2857.32 | -1086.23 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 3,766 | -24,425 | -13,335 | 8,643 | -22,413 | 8,073 |
Capital Expenditures CapEx Growth | -701.05 | -3,708 | -47,682 | -62,516 | -45,925 | -47,309 |
Free Cash Flow Free Cash Flow Growth | 3,065 | -28,132 | -61,017 | -53,873 | -68,338 | -39,235 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 17.82% | 12.60% | 28.92% | 34.17% | 31.71% | 35.75% |
Operating Margin | -25.91% | -36.62% | -5.51% | 0.43% | -3.41% | -3.71% |
Pretax Margin | -23.46% | -71.16% | -29.11% | -14.53% | -35.05% | 7.74% |
Profit Margin | -23.66% | -71.36% | -30.41% | -14.56% | -32.72% | 2.99% |
FCF Margin | 6.37% | -67.01% | -35.15% | -33.69% | -47.36% | -31.42% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | - | 166.29 |
Forward PE | - | 67.82 | 67.82 | 67.82 | 67.82 | 67.82 |
PS Ratio | 1.30 | 2.36 | 1.22 | 2.58 | 2.63 | 4.97 |